PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-9.93%
Revenue decline while MCHP shows 3.98% growth. Joel Greenblatt would examine competitive position erosion.
2.50%
Similar cost growth to MCHP's 2.82%. Walter Schloss would investigate if industry cost pressures are temporary.
-29.32%
Gross profit decline while MCHP shows 5.13% growth. Joel Greenblatt would examine competitive position.
-21.54%
Margin decline while MCHP shows 1.10% expansion. Joel Greenblatt would examine competitive position.
-55.74%
R&D reduction while MCHP shows 1.54% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-39.72%
Operating expenses reduction while MCHP shows 2.66% growth. Joel Greenblatt would examine advantage.
-15.94%
Total costs reduction while MCHP shows 2.77% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
12.31%
D&A growth 50-75% of MCHP's 17.81%. Bruce Berkowitz would examine asset strategy.
70.19%
EBITDA growth exceeding 1.5x MCHP's 11.04%. David Dodd would verify competitive advantages.
66.90%
EBITDA margin growth exceeding 1.5x MCHP's 6.79%. David Dodd would verify competitive advantages.
89.00%
Operating income growth exceeding 1.5x MCHP's 7.89%. David Dodd would verify competitive advantages.
87.79%
Operating margin growth exceeding 1.5x MCHP's 3.75%. David Dodd would verify competitive advantages.
-11.36%
Other expenses reduction while MCHP shows 861.29% growth. Joel Greenblatt would examine advantage.
110.90%
Pre-tax income growth exceeding 1.5x MCHP's 10.32%. David Dodd would verify competitive advantages.
112.10%
Pre-tax margin growth exceeding 1.5x MCHP's 6.10%. David Dodd would verify competitive advantages.
-94.39%
Tax expense reduction while MCHP shows 18.25% growth. Joel Greenblatt would examine advantage.
103.86%
Net income growth exceeding 1.5x MCHP's 7.65%. David Dodd would verify competitive advantages.
104.28%
Net margin growth exceeding 1.5x MCHP's 3.53%. David Dodd would verify competitive advantages.
105.56%
EPS growth exceeding 1.5x MCHP's 7.11%. David Dodd would verify competitive advantages.
105.56%
Diluted EPS growth exceeding 1.5x MCHP's 7.11%. David Dodd would verify competitive advantages.
0.07%
Share count change of 0.07% while MCHP is stable. Bruce Berkowitz would verify approach.
0.33%
Diluted share change of 0.33% while MCHP is stable. Bruce Berkowitz would verify approach.